Ganciclovir prophylaxis in CMV high-risk renal transplant recipients.

被引：0
|
作者：
Kletzmayr, J [1 ]
Safar, T [1 ]
Kovarik, J [1 ]
Klauser, R [1 ]
机构：
[1] UNIV VIENNA, DEPT NEPHROL & DIALYSIS, A-1010 VIENNA, AUSTRIA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1997年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A3210 / A3210
页数：1
相关论文
共 50 条
  • [1] Prophylaxis of cytomegalovirus (CMV) disease in high-risk renal transplant recipients. A randomized comparison of valacyclovir with oral ganciclovir
    不详
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2005, 28 (02): : 98 - 98
  • [2] Valganciclovir is effective prophylaxis for CMV in high risk renal transplant recipients.
    Baillie, GM
    Ashcraft, EE
    Taber, DJ
    Stone, SS
    Emovon, O
    Rogers, J
    Afzal, F
    Lin, A
    Rajagopalan, PR
    Baliga, PK
    Chavin, KD
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 377A - 377A
  • [3] Oral ganciclovir prophylaxis of cytomegalovirus (CMV) disease in pediatric renal transplant recipients.
    Feneberg, R
    Weber, LT
    Fickenscher, H
    Toenshoff, B
    [J]. PEDIATRIC TRANSPLANTATION, 2005, 9 : 118 - 118
  • [4] The problem of cytomegalovirus (CMV) prophylaxis in high-risk renal transplant recipients
    Maiwald, J
    Sperschneider, H
    Stein, G
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (09) : 1897 - 1897
  • [5] GANCICLOVIR IN CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK PEDIATRIC RENAL-TRANSPLANT RECIPIENTS
    PROKURAT, S
    DRABIK, E
    GRENDA, R
    VOGT, E
    [J]. TRANSPLANTATION PROCEEDINGS, 1993, 25 (04) : 2577 - 2577
  • [6] Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir
    Palmer, SM
    Grinnan, DC
    Reams, BD
    Steele, MP
    Messier, RH
    Davis, RD
    [J]. CLINICAL TRANSPLANTATION, 2004, 18 (02) : 179 - 185
  • [7] An RCT of ganciclovir prophylaxis for CMV disease in pediatric liver transplant recipients.
    King, SM
    Superina, R
    Andrews, W
    Winston, D
    Dunn, S
    Colombani, P
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 243 - 243
  • [8] Prophylactic oral Ganciclovir prevents cytomegalovirus disease in high-risk renal transplant recipients.
    Singer, GG
    Storch, GA
    Burton, KG
    Lippmann, BJ
    Buller, RS
    GaudreaultKeener, M
    Lowell, JA
    Shenoy, S
    Howard, TK
    Brennan, DC
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3469 - A3469
  • [9] Cytomegalovirus immune globulin therapy for CMV prophylaxis in high-risk renal allograft recipients.
    Amenábar, JJ
    Muñiz, ML
    Martínez, MP
    Bilbao, J
    Figuero, MP
    Gómez-Ullate, P
    Lampreabe, I
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (01) : 369 - 369
  • [10] Ganciclovir vs. valganciclovir for CMV prophylaxis in solitary pancreas transplant recipients.
    Rea, DJ
    Kudva, YC
    Larson, TS
    Stegall, MD
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 380 - 380
12345